By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunocore Limited 

90 Park Drive
Milton Park
Abingdon  Oxon  OX14 4RY  United Kingdom
Phone: 44-0-1235-438600 Fax: 44-0-1235-438601



Company News
MediGene AG (MDGEF.PK) Sells Partial Stake In Immunocore 4/4/2016 11:44:27 AM
Immunocore's IMCgp100 Starts Phase I Trial For The Treatment Of Uveal Melanoma 3/30/2016 7:20:42 AM
Immunocore’s IMCgp100 Granted Orphan Drug Designation By U.S. FDA For The Treatment Of Uveal Melanoma 1/25/2016 11:22:50 AM
Immunocore Starts Clinical Trial With IMCgp100 In Combination With MedImmune (AZN) Immunotherapies Durvalumab And Tremelimumab 1/20/2016 6:02:01 AM
Immunocore And GlaxoSmithKline (GSK) Select First ImmTAC Clinical Candidate In Discovery Collaboration 1/6/2016 9:46:35 AM
Immunocore Raises $5 Million Series A Financing To Advance Novel Cancer Immunotherapies 12/21/2015 4:51:39 PM
Immunocore Wins Biotech Of The Year At The SCRIP Awards 2015 12/3/2015 10:05:28 AM
Immunocore's IMCgp100 Accepted For Adaptive Pathway Pilot Programme 9/9/2015 8:17:10 AM
Immunocore Announces Fidelity’s Participation In $320M Financing 7/29/2015 8:57:08 AM
Eli Lilly (LLY) And Immunocore Limited Announce Immunotherapy-based Clinical Trial Collaboration In Melanoma 6/29/2015 6:46:17 AM